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ABSTRACT 
SYNTHESIS TOWARDS SYNTHETIC 
ADENOSINE RECEPTOR 
by 
Rajni Gupta 
Adenosine is a biologically important molecule as it acts as local modulator with 
cytoprotective function in the body. Adenosine accumulates in the extracellular space in 
response to metabolic stress and cell damage, and elevations in extracellular adenosine 
level are found in conditions like myocardial ischemia, hypoxia, inflammation and 
trauma. Its abnormal concentration therefore could be a marker of many diseases. 
Therefore determining its concentration can help understand the physiological state of the 
body. However its selective detection by synthetic receptors is not possible till date. 
            Efforts have been made here to design molecular tweezer for adenosine. Multistep 
synthesis was done to synthesize two clamps, namely the π-π stacking clamp and the 
hydrogen bonding clamp for the proposed tweezer. These two clamps in coordination 
with Zn+2 ions intended to form a pre-organized tweezers molecule for more favorable 
complexation with adenosine.  
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CHAPTER 1 
INTRODUCTION 
 
1.1 Biological Importance of Adenosine 
Adenosine is an endogenous nucleoside and is ubiquitous in mammalian cell types.  
Adenosine is related both structurally and metabolically to bioactive nucleotides like 
adenosine triphosphate (ATP), adenosine diphosphate (ADP), adenosine monophosphate 
(AMP), cyclic adenosine monophosphate (cAMP) and structurally to the coenzymes 
NAD, FAD and coenzyme A (Figure 1.1). Adenosine and its related compounds are 
important in the regulation of many aspects of cellular metabolism.1 Adenosine is 
produced in many cell types with extracellular concentration in submicromolar range. 
However, its levels are quite variable depending upon the tissues and degree of stress 
experienced. There are primarily two pathways for the biosynthesis of adenosine. The 
first is a cascading hydrolysis pathway, from 5'-ATP to 5'-ADP to 5'-AMP to adenosine 
both extracellularly and intracellularly. The second is an intracellular enzymatic 
conversion of S-adenosinesylhomocysteine to adenosine.2  
Extracellular adenosine is now known to regulate a diverse range of physiological 
functions, to the extent that almost all mammalian organ systems are affected by 
adenosine. Adenosine accumulates in the extracellular space in response to metabolic 
stress, cell damage and elevations are found in conditions like ischaemia hypoxia 
inflammation and trauma.3 Adenosine is proposed to function as a paracrine homeostasis 
modulator. First, extracellular adenosine represents a pre-eminent alarm molecule that 
report tissue injury to surrounding tissue. Second, extracellular adenosine generates a 
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range of tissue responses as organ protection thereby mediating homeostasis.4 The central 
activities of adenosine are also implicated in the molecular mechanisms underlying 
sedation, hypnosis, schizophrenia, anxiety, pain, respiration and depression. Adenosine 
has been proposed to be an endogenous anticonvulsant agent, inhibiting glutamase 
release from excitory neurons and inhibiting neuronal firing. Also, adenosine is an 
antiarrythmic agent and is thought to improve the symptoms of Parkinson’s disease. 
   
N
N
N
N
NH2
O
OHOH
OH N
N
N
N
NH2
O
OHOH
OP
O
OPOP
O
OH
O
OH OH
OH
N
N
N
N
NH2
O
OHOH
OP
O
OPOH
O
OH OH
N
N
N
N
NH2
O
OHOH
OP
O
OH OH
N
N
N
N
NH2
O
OHO
O
P
OH O
N
N
N
N
NH2
O
OHO
OP
O
OPO
O
O
- O
-
P
O
O
-
O
-
NH
NH
SH O
O
OH
Adenosine ATP
ADP AMP
cAMP Coenzyme A          
 
 
 
Figure 1.1 Structure of adenosine and related compounds.  
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The physiological responses to adenosine are complex and exerted through the 
activation of specific cell surface receptors. Four adenosine receptors A1, A2A, A2B and 
A3 are known so far. These are seven transmembrane glycoprotein receptors (Figure 1.2) 
and belong to the super family of G protein coupled receptor (GPCR).                        
 
                               
Figure 1.2 Structural motif of A2A adenosine  receptor.5  
 
 
Activation of adenosine receptors by adenosine initiates signal transduction 
mechanisms and various physiological effects are produced depending on the receptor 
subtype type and the metabolic state of the tissue in our body. It is worth mentioning that 
these natural receptors can distinguish between adenosine and other similar molecules 
like adenosine monophosphate (AMP) and adenosine triphosphate (ATP).  
 If one could determine the concentration of adenosine, underlying cause for some 
of the diseases can be found out. Therefore it is important to develop receptors that can 
specifically detect adenosine.  
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Several attempts were made time to time to develop synthetic receptors for 
adenine and its derivatives. Rebek et al.6 had developed a receptor (1) for adenine 
derivatives with an association constant of 11,000 M-1 in chloroform. This receptor 
utilized two hydrogen bonds and a π-stacking interaction to complex 9-ethyladenine. 
They also described the increased advantage of polarizability of the larger aromatic 
surface for the interaction of the receptor to the adenine derivatives. 
                                               
                   1                                        2                                                                       
Wilcox et al.7 reported the importance of orderly interrelationship of functional 
groups on the receptor (2) for binding adenine derivatives and utilized only hydrogen 
bonding for binding 9-ethyladenine to the receptor with an association constant of 4.5 ± 
1.7 x 104 M-1 in chloroform. Polymer with strong binding interactions to adenine were 
prepared by copolymerization of cross-linking monomers such as ethylene glycol 
dimethacrylate and N,N’-1,3-phenylenebis (2-methyl-2-propenamide) with methacrylic 
acid with a comparable association constant.8 All of the above reported receptors were 
selective for adenine, had low water solubility and cannot be used for adenosine binding.  
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Some synthetic receptors do show binding with adenosine or its derivatives but 
the association constants are quite small in comparison for adenine. Zimmerman9 
developed a molecular tweezer (3) that is more selective to purines in comparison to 
pyrimidines. This tweezer forms 1:1 complex 4 with 9-propyl adenine with an association 
constant of 25,000 M-1 in chloroform.  It also demonstrated selectivity for nucleoside 
derivatives, the association constant for adenosine derivative being 15,500 M-1 in 
chloroform.  
              
                                  3                                                                    4 
Molecular recognition ability of cyclophanes is also exploited by various groups. 
Inouye et al.10 demonstrated how pyreneophanes could be functionalized to alter their 
selectivities. Amphiphilic poly(oxyethylene)-substituted pyrenophane (5) showed good 
affinity for monopyrenyl guests, regardless of the guest being cationic, anionic or neutral. 
Polycationic hexaammonium pyrenophane and bis (diazoniacrowm)-substituted showed 
affinity for anionic guests. The latter one preferred triphosphate nucleotides (1000 times) 
rather than di- or monophosphate nucleotides or nucleosides. 
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                                                               5                                                                                                      
Adenosine aptamers have been developed, although they are not selective for 
adenosine over ATP. These aptamer sensors have been developed by conjugation of 
adenosine aptamers with colored nanoparticles, malachite green aptamer, and G-
quadruplex DNAzyme.11-12 
 
1.2 Molecular Tweezers 
Non-covalent interactions are of fundamental importance to all biological processes. This 
has inspired the study of host-guest chemistry whose goals include the development of 
artificial receptors and the understanding of complexation phenomena.13 Host-Guest 
chemistry involves two or more molecules, a “host” and a “guest”, involved in non 
bonding interactions to form a supramolecular complex. According to Cram hosts and 
guests as organic molecules or ions whose binding sites converge and diverge, 
respectively, in forming a complex.14 This host-guest chemistry encompasses the idea of 
molecular recognition and thus widely used in the synthesis of receptors/sensors for 
biological molecules, metal ions and many more. Most common host molecules include 
calixarenes, crown ethers, cyclodextrin, cryptophanes, cucurbitis and porphyrins. All 
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these have large rigid cavities in which they encapsulate small molecules. However, these 
macrocycles are difficult to synthesis and functionalize for selective binding.  
Another class of host, called as molecular tweezers, a term coined by Whitlock,15 
was developed and popularized by Steven C. Zimmerman. These are noncyclic 
macromolecular complexes and contain pre-organized aromatic clefts, which are capable 
of binding guest’s molecules using π-π stacking and hydrophobic interactions. Additional 
hydrogen bonding and metal co-ordination may be introduced to enhance specific 
recognition. More sophisticated molecular tweezers carry an additional functional group 
oriented toward the aromatic cleft so that π-stacking and hydrogen bonding can occur 
simultaneously. Typically, these hosts contain two aromatic chromophores covalently 
linked by a single spacer unit. A suitable spacer will allow π-surfaces of the molecular 
tweezers to converge on the two divergent π-faces of an aromatic guest in a sandwich 
complex held together by two π-stacking interactions.16 
In organic solvents, the association of aromatic chromophores is well 
documented. A favorable interaction generally occurs only when one partner is a π-donor 
and the other is π-acceptor.17 The electron donor-acceptor complexes formed between π-
donors and π-acceptors are believed to be held together by electrostatic, dispersion and 
charge transfer forces. These forces are weak with association constant in common 
organic solvents generally ranging from 0.1 to 1000 M-1, but usually less than 10 M-1. In 
aqueous environment, enhancement of the association constant occurs by hydrophobic 
interactions. 
           Interest in molecular tweezers relates to their potential for increasing the stability 
of electron donor acceptor complexes by forming π-sandwiched complex. Whether such a 
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complex forms and the second chromophore contributes significantly to the stability of 
the complex depends upon many factors, including the enthalpic strength of the second π-
stacking interactions and the enthalpic and entropic loss necessary for adopting the 
required geometry. During the past 30-35 years, a considerable research effort has been 
placed toward obtaining molecular tweezer type of receptor molecules specific for an 
analyte of interest. 
 
1.3 Design of Molecular Tweezers 
Supramolecular chemistry has developed the construction of receptors whose shape and 
structural features allow for selective binding of various guests through non-covalent 
interactions.18 Among the rich variety of receptors, molecular tweezers constitute a 
special recognition platform displaying intercalation of an aromatic substrate inside the 
cavity of the receptor. In designing molecular tweezers, both complexing chromophores 
and an appropriate spacer unit must be chosen. The property of the chromophores that is 
most likely to affect the complexation strength is its π-donor and acceptor strength. The 
shape and size of the chromophores are also important. However, the critical element of 
the molecular tweezers is the spacer unit.16 The optimum spacer acts like a hinge such 
that the interplanar distance between two aromatic plates (formed by chromophores) 
forms a pocket suitable for binding planar guest molecules. Also, the spacer must be rigid 
enough to hold the molecular tweezers in a pre-organized conformation for more 
favorable complexation. Chen and Whitlock described how increasing rigidity of the 
spacer in molecular tweezer (6) increased the binding power over saturated analogue and 
thus prevented self association of the caffeine rings.15 Further, they reported that caffeine-
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caffeine distance in syn conformation is about 7 Å, which is perfect for insertion of 
aromatic system between the rings if the spacer can maintain a syn-orientation. 
Zimmerman had also described the increase in association constant between the more 
rigid tweezer 7 and the guest by further increasing the rigidity of the original molecular 
tweezer.9 
                                                                                           
                           6                                                       7 
Finally, the molecular tweezers should be easy to synthesize. Ideally, the synthetic 
route should be sufficiently flexible to allow attachment of different groups for selective 
binding of guests. Schrader shaped a tweezer (8) for noradrenaline19 which was 
accessible by a short and convergent synthesis, biphenylic side walls were linked to an 
aromatic diaminophenazine head group by amide coupling. Intramolecular hydrogen 
bond between both amide protons and the phenazine ring nitrogen fixed this tweezer at an 
aromatic distance of 7.0 Å and oriented the amide protons inwards for catechol 
recognition, phosphonate anions were ideal for recognition of ammonium alcohol moiety. 
10 
 
  
                                            
                                                               8        
Recently, Lehn20 et al. reported a terpyridine based molecular tweezer (9) which 
transforms into the desired compact conformation only when zinc is coordinated to the 
terpyridine moiety. In complex 10, the two terminal α,α'-linked π-donor pyrene units are 
situated in a face to face arrangement suitable for the insertion of a flat aromatic π-
acceptor between their parallel planes, thus yielding π-π stacking of three overlapping 
aromatic rings. 
 
                        9                                            10a                                     10b 
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In the present thesis, efforts have been made to develop a synthetic adenosine 
receptor. For this purpose, it is proposed to synthesize a molecular tweezer having 
terpyridine as spacer which is connected to anthracene chromophores via phenyl 
acetylene linkers. The Lehn tweezer described above formed the framework for the 
proposed tweezer structure. It will attain a binding conformation when Zn is coordinated 
in the linker site (Figure 1.3).  Another terpyridine unit when sandwiched by the outer 
clamp can be functionalized desirably. The attachment of specific recognition motif to 
the tweezed terpyridine will result in another clamp that will be orthogonal to the first 
one. It was anticipated to adopt a U-shaped conformation, placing the two substituent at 
6,6'' position of the terpyridine in parallel planes, well adopted for donor/acceptor π-π 
interactions. 
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Figure 1.3 Proposed molecular tweezer for adenosine binding.  
 
To make an aromatic cleft for adenosine, two uracil rings are proposed to be 
attached to a terpyridine via phenyl acetylene linkers. These uracil rings will serve as 
recognition motif for adenosine as well as will provide extra hydrogen bonding 
interactions. These extra hydrogen bonding interactions will help stabilizing the U-A-U 
12 
 
  
complex formed by the tweezer as they stabilize T-A-T complex in DNA triplex. This 
uracil-adenosine-uracil complex will have π-π stacking interactions with two anthracene 
groups. Thus, this molecule tweezer has both, a π-π stacking clamp and a hydrogen 
bonding clamp. These interactions will greatly stabilize the proposed complex. 
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Figure 1.4 Structures of scaffold I and II.  
 
For the proposed double molecular tweezer, two different molecular clamp 
synthesis were attempted. One was the π-π stacking clamp (scaffold I) and other being 
hydrogen bonding clamp (scaffold IIA and IIB) (Figure 1.4). These two clamps were 
proposed to attain the desired conformation in the presence of zinc ions.  
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The binding of adenosine to the proposed receptor will be tested by fluorescence 
experiments. The literature shows that the emission of terpyridine substituted 
fluorophores is quenched by the addition of metal cations such as zinc. However, adding 
a second ligand to zinc-terpyridine complex helps to restore the fluorescence emission. It 
is expected that adding adenosine to the double tweezer will quench the fluorescence 
again. This pre-organized assembly could therefore serve as adenosine responsive 
system. Scaffold IIA is a simplified structure of scaffold IIB. Although this 
simplification could lead to loss of binding affinity, the synthesis of this tweezer was 
expected to be much easier than the scaffold IIB  
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CHAPTER 2 
SYNTHESIS OF π- π STACKING CLAMP 
 
Strong attractive interactions between π-systems have been known for over half a 
century. They control such diverse phenomena as the vertical base-base interactions 
which stabilize the double helical structure of DNA, the packing of aromatic molecules in 
crystal, the tertiary structures of proteins, the conformational preferences and binding 
properties of polyaromatic macrocycle, complexation in many host-guest systems and 
porphyrin aggregations.21 These π-π interactions are controlled by electrostatic as well as 
other energy contributions. π-π interactions are not due to an attractive electronic 
interaction between the two π-systems but occur when the attractive interactions between 
π-electrons and the σ-framework outweigh unfavorable contributions such as π-electron 
repulsion. Also there are geometric constraints imposed by the structure of the guest as 
well as the range of relative orientations available to the host and guest is usually limited. 
Beside the required electronic complementarity for the binding to occur through 
stacking interactions, the shape of the tweezer is of paramount importance. As stated 
previously, the scaffold of a tweezer has to be pre-organized so as to 1) be rigid in order 
to prevent the tweezer from collapsing, 2) position the two units interacting with the 
substrate, the “arms”, at an optimal distance of 7 Å from each other and 3) orient these 
arms in a syn conformation.  
A scaffold based on 6,6''-difunctionalized 2,2': 6,2''-terpyridine indeed seems to 
be a potential candidate to fulfill these requirements when complexed to a metal ion. The 
terpyridine molecule contains three nitrogen atoms and can therefore act as a tridentate 
15 
 
  
ligand and form stable complexes by chelating a broad variety of transition metal ions. 
Terpyridine forms distorted octahedral complexes showing different stabilities from 
kinetically inert (e.g., Ru(II)  and Ni(II)) to labile (e.g. Zn(II)).22 The terpyridine unit 
could be linked to various π-donor groups to have stacking interactions with the guest 
molecules. Various linkers can be used; the present study focuses on the use of phenyl 
acetylene linker so that the cavity formed is big enough to hold the second scaffold. Also, 
this scaffold has extended conjugated system and therefore is strongly fluorescent. 
Based on the structure of scaffold I, a retrosynthetic scheme was constructed that 
led to the recognition of readily available related compounds as starting materials. As 
shown in Scheme 1, it was envisioned that 11 and 12 would be coupled by Stille coupling 
which is a versatile palladium catalyzed C-C bond forming reaction between stannanes 
and organic halides.23 This coupling is performed under inert atmosphere as oxygen 
causes the oxidation of palladium catalyst and promotes the homo-coupling of stannyl 
compounds. The only drawback of the reaction is the toxicity of tin compounds and their 
low polarity. Stille coupling will be followed by deprotection. The alkyne obtained will 
be coupled with bromoanthracene (13) to provide scaffold I by Sonogashira coupling 
which is also a very known palladium-catalyzed reaction for coupling terminal alkynes 
with organic halides.24 The segment 11 could be derived from 14 and 15 by Sonogashira 
coupling.        
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Scheme 1: Retrosynthetic analysis of scaffold I. 
Scheme 2 outlines the attempted synthesis of scaffold I. Synthesis of I began by 
stannylation of commercially available (4-bromo-phenylethynyl)-trimethyl-silane (14) 
with trimethyltin chloride (15) at the bromide position in presence of n-BuLi to afford 11. 
Although inseparable small amounts of byproducts were obtained, it was assumed that 
these byproducts would not interfere in the following reaction. Stannane 11 was coupled 
with 12 in presence of lithium chloride by Stille coupling reaction. Initially, ethyl acetate 
was used for extraction. It was later realized that the product from above reaction did not  
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Scheme 2: Attempted synthesis of scaffold I. 
have good solubility in ethyl acetate. Therefore, in the second attempt, methylene 
chloride was used instead to obtain crude product. The crude obtained from the above 
reaction was purified by flash chromatography and analyzed by NMR. However, NMR 
showed the presence of extra protons in the aromatic region. Probably, coupling did not 
occur at both the bromide positions of terpyridine. It is possible that hydrogen bromide 
formed during the reaction interfered with coupling at second bromide position. 
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Therefore, the product from the above reaction was put back again for the same reaction. 
Additionally, triphenylarsine was added to activate the palladium catalyst in the zero 
oxidation state. The reaction was completed in 24 h and again purified by column 
chromatography and confirmed by NMR analysis. This was then deprotected by using t-
butyl ammonium fluoride (TBAF). Unfortunately, NMR spectra showed unexpected 
peaks in the aliphatic region which indicated the presence of TBAF as impurity. Then, 
methanolic sodium hydroxide was employed for the deprotection. The product was 
extracted into the organic the organic layer and was easily separated from sodium 
hydroxide. This crude product was purified by flash chromatography to give 17 in 60% 
yield.  
Compound 17 reacted with 9-bromoanthracene (13) under Sonogashira reaction 
conditions25 to yield Scaffold I. The reaction was originally carried out in deoxygenated 
toluene at 100°C employing TEA as a base, later it was also tried in THF at 60°C. Though 
purification was attempted using flash chromatography, TLC showed mixture of 
products. Consequently, preparative TLC was done to separate the mixture and two 
fractions were isolated. Both of them were highly fluorescent as expected. Surprisingly, 
the ESI Mass spectra of the neither of the two fractions matched the expected molecular 
ion peak, though one fraction (I-a) showed M-2 ion peak (Figure 2.1). Essentially, since 
Scaffold I had only aromatic protons, it was also difficult to identify it with 1H NMR.  
Fluorometry experiments were done (Figure 2.2b & c) to study the effect of addition of 
zinc triflate to I-a as zinc is known to drive the chelation enhanced quenching of the 
several fluorescent system.26 It was observed that addition of zinc triflate at 10-9 M conc. 
of the product quenched the fluorescence but at a higher concentration, results obtained 
19 
 
  
were different which could be due to self-association of the molecules in solution at 
higher concentration. However, when fluorometry experiments were performed with 16 
(Figure 2.2a), fluorescence emission was increased upon the addition of zinc triflate. It is 
evident that an unknown reaction happened between 17 and 13, 
although the desired product was not finally obtained. The structure shown below could 
be the expected structure of I-a, though it is not characterized yet. 
 
                                
                                              I-a 
20 
 
  
 
 
Figure 2.1 Mass spectrum of I-a.  
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Figure 2.1 Mass spectrum of I-a (Continued).  
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Figure 2.2 (a) Fluorescence spectra of 16 at 10-8 M concentration. Fluorophore 16 was 
excited at 300 nm. Red, 16. Blue, 16 with 0.5 equivalents of Zn (OTf)2. Green, 16 with 
1.0 equivalents of Zn(OTf)2. (b) Fluorescence spectra of I-a at 10-9 M conc. and 300 nm. 
Green, I-a. Blue, I-a with 0.5 equivalents of Zn(OTf)2. Red, I-a with 1.0 equivalents of 
Zn(OTf)2. 
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Figure 2.2 (c) Fluorescence spectra of I-a at 10-7 M conc. and 300 nm. Red, I-a. Blue,I-a 
with 0.5 equivalents of Zn(OTf)2. Green, I-a with 1.0 equivalents of Zn(OTf)2. 
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CHAPTER 3 
SYNTHESIS OF HYDROGEN BONDING CLAMP IIA 
 
Hydrogen bonding plays an important role in determining the three dimensional structure 
adopted by chemical and biological system as a consequence of their specificity and 
directionality. The double helical structure of DNA, for example, is due largely to 
hydrogen bonding between the base pairs which link one complementary strand to the 
other. The formation of one or multiple hydrogen bonds, especially in combination with 
other non-covalent forces, such as ionic or hydrophobic interactions, can lead to a 
dramatic change in the micro- and macroscopic properties of the resulting supramolecular 
assemblies.27 In contrast to covalent bonds, which once formed are stable under normal 
conditions and can only be broken by providing sufficient energy, the formation of 
hydrogen bonds is reversible and their strength depends on the chemical environment, 
such as the solvent or temperature. Through a variation of the external parameters, this 
reversibility allows for the direct control of those physical properties of supramolecular 
assemblies which are determined by the hydrogen bonds. 
Hydrogen bonding forces are cooperative in nature. Based on this principle, 
chemists have developed wide variety of chemically stable structures. Research groups of 
Lehn and others have extended this work to synthetic receptors and demonstrated these 
interactions have an enormous potential for the construction of chemical structures 
exhibiting a high degree of complexity. However, that can happen only when the 
synthetic molecules are encoded with the appropriate H-bonding information and 
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geometry.28 Most frequently, derivatized heteroaromatic molecules are used as module 
since their flat shape and rigidity optimally ensures the formation of 2D assemblies. 
The proposed scaffold for adenosine binding has two uracil units, the carbonyl 
oxygen of which can form hydrogen bonds with the guest, adenosine. This hydrogen 
bonding system resembles a DNA triplex and would make use of Watson-Crick and 
Hoogsteen base pairing. 
                                   
Figure 3.1 Hydrogen bonding interactions between scaffold IIA and adenosine.  
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Scheme 3: Retrosynthetic analysis of scaffold IIA.                                                          
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Based on the retrosynthetic analysis of the scaffold IIA, it was envisioned that the 
scaffold could be made from molecules 18, 19 and 20. Initially, the synthesis of 
pyridinedicarbaldehyde 18 was attempted using dibromopryidine and n-butyllithium (1:2 
equivalents, respectively) in DMF. However, NMR did not suggest the expected product. 
Then 18 was synthesized by Swern oxidation29 of pyridinedimethanol by oxalyl chloride 
in DMSO and methylene chloride at -78°C. Later anhydrous triethylamine was added and 
the reaction flask was warmed to room temperature in 2 h. The reaction yielded the 
desired product 18 in low yield.  
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Scheme 4: Attempted synthesis of scaffold IIA. 
In the second attempt, the reaction flask temperature was slowly raised to room 
temperature over 12 h. The yield was significantly improved to 55%. Propargylation of 
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pyridinedicarbaldehyde could be achieved by using TMS propargyl bromide. In this kind 
of reaction, a mixture of two products, allenic alcohols and homopropargyl alcohols is 
often obtained. However, regioselectivity of the indium-mediated reaction of TMS 
propargyl bromide with carbonyl compounds towards the synthesis of either of the 
alcohols can be controlled by the judicious choice of the reagents and other reaction 
conditions. It was reported that excellent regioselectivities can be obtained when the 
reactions were carried out in THF in the presence of catalytic amount of indium 
trifluoride.30 Moreover, homopropargylic alcohols were reported at high temperature with 
excellent selectivities  when aldehyde: TMS propargyl bromide: Indium was taken in the 
ratio of 1:2:2. In contrast, when the reaction was done at room temperature, allenic 
alcohol was the major product. Efforts have been made to synthesis the homopropargyllic 
alcohol 21 by the above stated methods. Pyridinedicarbaldehyde, Indium and TMS 
propargyl bromide were taken in THF in 1:4:4 ratios and 0.2 equivalents of Indium 
trifluoride were added. The reaction was refluxed overnight under argon, filtered and then 
quenched with 0.1 M HCl solution. Ammonium acetate buffer was added to avoid the 
mixture becoming too acidic to protonate pyridine. However, NMR indicated that 
pyridine structure had changed during the reaction but the desired product was not 
observed. However, when the reaction was carried at room temperature conditions, 
allenic alcohol was obtained in 33 % yield.  
Since the propargylation of 18 did not work, efforts were made to directly 
synthesize 22 by reaction of 18 with substituted thiazolium iodide31 and TMS-propargyl 
bromide in the presence of base followed by deprotection. Aldehyde: Thizolium iodide: 
and NaOH were mixed in 1:2:2 ratios, followed by addition of TMS-propargyl bromide. 
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The reaction was carried out at room temperature and later purified by flash 
chromatography. However, only starting material 19 was obtained. It is likely that the 
intermediate formed between the aldehyde and thiazolium iodide was not reactive to 
TMS-propargyl bromide. 
Analyzing scaffold in a different way, it was envisioned that scaffold could also 
be made from molecules 23 and 24, 24 in turn can be obtained from 20 and 25. 
                   
N
NHNH NHNH
O O
O O
O O
N
CH2BrBrH2C
O O N
H
NH
O
OTMS
N
H
NH
O
O
I
TMS
23 24
25 20
Scaffold IIA
+
+
 
Scheme 5: Retrosynthetic Analysis of scaffold IIA.     
 
Synthesis of IIA was started using commercially available 2,6-diacetylpyridine. 
Bromination of the above compound was carried out by treating it with two equivalents 
of bromine in chloroform. The reaction was run for 2 h under room temperature condition 
and later crystallized in acetone. But the NMR analysis of the product indicated 
bromination at only one position. In the second attempt, the reaction time was increased 
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to 48 h but the same monobrominated product was observed. It seems probable that 
hydrogen bromide generated during the course of the reaction formed an insoluble 
material with pyridine which stopped further reactions. Thus, the monobrominated 
compound was again treated with one equivalent of bromine at room temperature. NMR 
confirmed the formation of the desired bis(bromoacetyl) pyridine 23.  
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Scheme 6: Attempted Synthesis of scaffold IIA.        
 
Commercially available 5-iodouracil and acetylene trimethylsilane were coupled 
together by palladium-catalyzed Sonogashira cross-coupling reaction under inert 
atmosphere to afford 24.  DMF and triethylamine were used in the ratio of 1:3 as reaction 
solvent as solubility of uracil compounds is generally a problem. 24 was then deprotected 
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using methanolic sodium hydroxide to give a terminal alkyne 26. Since the alkyne proton 
is weakly acidic, usually strong bases are required for deprotonation. A convenient 
alternative is to convert them into metal acetylides, the acetylides anions thus obtained 
are very good nucleophile and thus can react with bromo compounds to give the 
substitution product. Therefore 26 was treated with cupric iodide to form copper 
acetylide. Since the acetylide are sensitive to air, they were not isolated and taken as such 
for further reaction with 23 under argon. Unlikely, the desired scaffold could not be 
obtained. To avoid the possibility of triethylamine consuming the dibromide starting 
material by forming quaternary amine and hence 5-iodouracil getting homocoupled, 
triethylamine was replaced by a bulkier base diisopropylethylamine (DIPEA). However, 
this change did not give the desired product either. Two distinct fractions were collected 
from the column. One fraction was quite similar to the ethynyl uracil (26) and the other 
fraction had a lot more aromatic protons than expected and could not be identified. The 
failure of the reaction could be caused by the poor solubility of the metal acetylide of 26.  
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CHAPTER 4 
SYNTHESIS OF HYDROGEN BONDING CLAMP IIB 
 
The scaffold described in Chapter 3 could not be made successfully, therefore another 
hydrogen bonding clamp was proposed for recognition of adenosine. This scaffold 
involves two uracil units, the carbonyl oxygen atoms of which are expected to form 
hydrogen bonds with the guest, adenosine. This hydrogen bonding system resembles a 
DNA triplex and makes use of Watson-Crick and Hoogsteen base pairing. In contrast to 
scaffold IIA which has a pyridine diketone spacer, this scaffold has terpyridine unit as 
spacer.  
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 Scheme 7: Retrosynthetic analysis of scaffold IIB.      
32 
 
  
Retrosynthetic analysis of scaffold IIB revealed that it could be made from 20, 
25, 27 and 28. Among several approaches to obtain alkynes, attention has been devoted 
to palladium-catalyzed cross-coupling reactions, taking into account that the reactivity of 
halogens towards coupling reactions is known to be I > Br >> Cl and that the positions 
ortho or para to the nitrogen of pyridine are usually reactive enough with chlorine to give 
acceptable yields of the coupled products, whereas meta positions require bromine, 
iodine or triflates for sufficient reactivity.32 
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Scheme 8: Attempted Synthesis of scaffold IIB.                                                         
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The Sonogashira reaction of 2-bromo-3-iodopyridine IIg with TMS-acetylene IIf 
was examined. The reaction was run overnight under argon atmosphere. Reaction gave 
the desired product in 50% yield after flash chromatography. TMS group was then 
removed in an overnight deprotection reaction using tetrabutylammonium fluoride 
reagent. The product was purified by column chromatography and gave 67% yield. The 
resulting 2-bromo-3-ethynylpyridine was sought to couple with 5-iodouracil under 
Sonogashira conditions. DMF was added in addition to the reaction mixture to increase 
the solubility of 5-iodouracil. The reaction yielded a strongly fluorescent product. 
However, NMR indicated the absence of uracil moiety in the product. It seemed probable 
that homo coupling of 2-bromo-3-ethynylpyridine occurred to afford the molecule below 
and uracil had not participated in the reaction.  
                                              
N
Br
N
 
Since 23 could not be made because of the presence of bromine, the future plan is 
to change the sequence of steps. First, 24 will be converted to stannane (25), which will 
be further coupled with dibromopyridine by Stille coupling followed by deprotection to 
give 27 which will then be coupled with 5-iodouracil to give the scaffold IIB. 
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Scheme 9: Future synthesis plan for scaffold IIB. 
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CHAPTER 5 
CONCLUSION 
 
The synthesis of π-π stacking clamp was completed though the final scaffold I structure 
could not be verified yet.  As expected, the synthesized molecule was strongly 
fluorescent. The addition of zinc triflate to its solution showed quenching in fluorescence. 
However, the synthesis of hydrogen bonding clamp scaffold IIA could not be achieved. 
Different approaches were tried for its synthesis. The scaffold IIA having pyridyl-β-
alkynyl-ketone group could be a typical structure that is difficult to synthesize. Synthesis  
of scaffold IIB is currently undergoing. 
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APPENDIX 
EXPERIMENTAL PROCEDURE 
 
The appendix describes the experimental details of the synthesis of the following: 
Trimethyl-(4-trimethylstannanyl-phenylethynyl)-silane (11): n-BuLi (2 mL, 5 mmol) 
was added dropwise at -78°C to a flask containing a solution of (4-bromo-phenylethynyl)-
silane (1.01g, 4 mmol) in THF (15mL) under argon. The reaction mixture was stirred for 
15 min before adding dropwise trimethyltin chloride (5 mL, 5 mmol). The solution was 
allowed to warm up at room temperature, stirred overnight and then quenched with 
methanol. After evaporation of the solvent, the crude material was purified by means of 
flash chromatography (silica/2% ethyl acetate in hexanes). Purification afforded 11 
(1.02g, 89%) as a clear liquid. 1H NMR (300 MHz, CDCl3) δ: 7.47 (s, 2H), 7.73 (s, 2H), 
0.28 (m, 18H). 
 
2,2ʹ:6,6ʹʹ-(6,6ʹʹ-diphenylethynyl-trimethyl-silanyl)-terpyridine (16): To a degassed 
mixture of 11 (390.92 mg, 1.16 mmol), 12 (181.42mg, 0.464 mmol), lithium chloride 
(491.724mg, 11.6 mmol), tetrakistriphenylphosphine palladium (26.8 mg, 0.0232 mmol) 
and triphenylarsine (14.21 mg, 0.0464 mmol) was added toluene under argon. The 
reaction mixture was refluxed for 48 h. The reaction vessel was cooled to room 
temperature and mixture quenched with water and extracted with methylene chloride. 
The organic layer was washed with brine, dried over magnesium sulfate and the solvent 
removed in vacuo. Purification by flash chromatography (silica/hexanes/CH2Cl2/ethyl 
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acetate 80:15:5) afforded the desired product 16 in low yield as cream powder. 1H NMR 
(300 MHz, CDCl3): δ 8.69-7.61 (m, 17), 0.29 (s, 18H). 
 
2,2ʹ:6,6ʹʹ-(6,6ʹʹ-diphenylethynyl)-terpyridine (17): Methanolic NaOH (0.4 g, 10 mmol) 
was added to a solution of 16 ( 27 mg, 0.047 mmol) in THF. The reaction mixture was 
stirred for 3 h and then quenched with water. The product was extracted with CH2Cl2. 
The organic layer was washed with brine, dried over magnesium sulfate and the solvent 
was removed on rotavap. Purification by flash chromatography (silica/hexanes/CH2Cl2 
1:2) afforded the desired product 17 in 60 % yield. 1H NMR (300 MHz, CDCl3): δ 8.69- 
7.6 (m, 17), 3.2 (s, 2H). 
 
2,6 -pyridinedicarbaldehyde (18): A solution of anhydrous DMSO (4.4g, 0.056 mol) in 
CH2Cl2 (6 mL) was added slowly dropwise to a stirred solution of oxalyl chloride (2.62 g, 
20.63 mmol) in CH2Cl2 at -78°C (the temperature of the reaction was maintained at 78°C 
until the addition of TEA). After the addition was complete, the solution was stirred for 5 
min, and then a solution of 2,6-pyridinedimethanol (1.00 g, 7.2 mmol) in anhydrous 
DMSO (4 mL) and CH2Cl2 (6 mL) was added dropwise over a period of 15 min. The 
solution was stirred for 20 min, during which time the formation of a white precipitate 
was noted. Anhydrous TEA (10 mL) was then slowly added dropwise to the reaction 
mixture. The reaction was let warm to room temperature, stirred overnight, and then 
poured into 50 mL of water. The layers were separated and the aqueous layer was 
extracted with 3x 35 mL of CH2Cl2. The combined organic extracts were washed with 
3x30 mL of brine, dried over magnesium sulfate and filtered. The solvent was then 
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removed under vacuo, and the tan solid was purified by flash chromatography (silica/ 
hexanes:ethyl acetate 3:1). Purification afforded 1.07 g of 15 in 55% yield. 1H NMR (300 
MHz, CDCl3): δ 10.14 (s, 2H), 8.16 (d, 2H), 8.06 (t, 1H) ppm. The 1H NMR matches the 
known 1H NMR of 2,6-pyridinedicarbaldehyde.29 
 
2,6–bis(bromoacetyl)pyridine (23) : 2,6 –diacetylpyridine (0.163 g, 1 mmol) was 
dissolved in CHCl3 (10 mL), to it was added bromine ( 107 µL, 2 mmol) and stirred 
overnight at room temperature. The reaction mixture was decanted to another flask and 
the solvent was evaporated on rotavap. Hexanes was added which partially dissolved the 
crude and then acetone was added at 40°C to make it completely soluble. It was left for 
crystallization.  The crystallized product showed bromination at only one of the two 
positions. To it was again added bromine (56 µL, 1 mmol) and the same procedure was 
followed for obtaining crystals of 19 in 62.3 % yield. 1H NMR (300 MHz, CDCl3): δ 
8.2(m, 2H), 8.6(m, 1H), 4.8 (m, 4H). 
 
5-ethynyluracil (26): 5-iodouracil (2 g, 8.4 mmol), tetrakistriphenylphosphine palladium 
(350 mg, 0.303 mmol), copper iodide (130 mg, 0.682 mmol) were degassed and 
suspended in ethyl acetate (40 mL). To it was added TMS acetylene (2 g, 8.4 mmol) 
under argon. The reaction mixture was stirred at room temperature for 3.5 h and filtered. 
The solid was transferred to 50 mL of 1M NaOH and stirred for 2 h and filterd. The 
filterate was then placed in an ice bath and acetic acid was added until pH reached 4.0. It 
was filtered and the collected solid was dried in air. The reaction afforded 26 in 100 % 
yield. 1H NMR (300 MHz, DMSO): δ 11.37 (br., 2H), 7.82 (s, 1H), 4.05 (s, 1H). 
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2-bromo-3-ethynylpyridine (29): To a degassed suspension of 2-bromo-3-iodopyridine 
(283 mg, 1.0 mmol), tetrakistriphenylphosphine palladium (35 mg, 0.03 mmol), copper 
iodide (13 mg, 0.07 mmol) in TEA (5 mL) and ethyl acetate (15 mL), was added TMS 
acetylene (98.2 mg, 1.0 mmol). The reaction mixture was stirred overnight under argon at 
room temperature and filtered. The solvent was evaporated on rotavap and the crude was 
purified by flash chromatography (silica/hexanes: ethyl acetate 9:1) to afford 21. 21 was 
then deprotected by dissolving in THF and adding tetrabutylammonium fluoride (315.51 
mg, 0.46 mmol) and stirring the reaction mixture overnight. Solvent was evaporated and 
the crude was purified by flash chromatography (silica/hexanes: ethyl acetate 9:1) to 
afford 29 in 41.12% yield. 1H NMR (300 MHz, CDCl3): δ 8.42 (m, IH), 7.86 (m, 1H), 
7.34 (m, 1H), 3.6 (s, 1H). 
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